Show simple item record

dc.contributor.authorOkoliegbe, Ijeoma N.
dc.contributor.authorHijazi, Karolin
dc.contributor.authorCooper, Kim
dc.contributor.authorIronside, Corinne
dc.contributor.authorGould, Ian M
dc.date.accessioned2021-08-13T10:53:01Z
dc.date.available2021-08-13T10:53:01Z
dc.date.issued2021-08-12
dc.identifier.citationOkoliegbe , I N , Hijazi , K , Cooper , K , Ironside , C & Gould , I M 2021 , ' Antimicrobial Synergy Testing : Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived ' , Antibiotics , vol. 10 , no. 8 , 967 . https://doi.org/10.3390/antibiotics10080967en
dc.identifier.issn2079-6382
dc.identifier.otherPURE: 198420491
dc.identifier.otherPURE UUID: 29532e3a-2dfa-4ee8-910d-fe16bffe8e8a
dc.identifier.otherScopus: 85113761255
dc.identifier.otherWOS: 000688660900001
dc.identifier.urihttps://hdl.handle.net/2164/16945
dc.descriptionFunding: This research was funded by the NHS Grampian Endowment fund, grant number EA9431, and the NHS Grampian Clinical Microbiology Fund (NHS Grampian Endowment Funds, Registered Charity Number SC017296). Acknowledgments: The authors would like to thank the laboratories and clinicians who use the Cystic Fibrosis Susceptibility Testing Service. CFASS is an adult patient-testing facility, funded by the National Services Division of the Common Services Agency of the Scottish Executive.en
dc.format.extent12
dc.language.isoeng
dc.relation.ispartofAntibioticsen
dc.rights© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).en
dc.subjectantimicrobialsen
dc.subjectceftazidimeen
dc.subjectcombination antimicrobial susceptibility testingen
dc.subjectgradient diffusionen
dc.subjectPseudomonas aeruginosaen
dc.subjectsynergy testingen
dc.subjecttobramycinen
dc.subjectR Medicineen
dc.subjectRK Dentistryen
dc.subjectOtheren
dc.subjectEA9431en
dc.subjectSupplementary Informationen
dc.subject.lccRen
dc.subject.lccRKen
dc.titleAntimicrobial Synergy Testing : Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Deriveden
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Dental Educationen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.3390/antibiotics10080967


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record